Spyre Therapeutics, Inc.
Engineering advanced antibody therapies for IBD and other immune diseases.
SYRE | US
Overview
Corporate Details
- ISIN(s):
- US00773J1034 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 221 CRESCENT STREET, 2453 WALTHAM
- Website:
- https://spyre.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Spyre Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing next-generation treatments for inflammatory bowel disease (IBD) and other immune-mediated diseases. The company's approach involves engineering advanced antibodies for prolonged activity in the body, which are formulated for delivery as monotherapies or combination therapies. Spyre's pipeline targets validated mechanisms to treat various gastrointestinal and rheumatic conditions, with the goal of providing patients with treatment options that offer enhanced efficacy and convenience.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Spyre Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Spyre Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Spyre Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
